当前位置:循环首页>正文

[AHA2009]Philip Greenland教授谈心血管疾病的预防

作者:国际循环网   日期:2009/11/26 17:33:00

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

International Circulation:Can you share with us your opinion about the role of prevention of cardiovascular disease, the role of cardiovascular diseas risk extimation in the prevention of cardiovascular disease, and the status in cardiovascular prevention? 《国际循环》:您能就心血管疾病预防的作用、在心血管疾病预防中心血管疾病风险评估的作用以及心血管疾病预防现状谈谈您的看法吗?

    International Circulation:Can you share with us your opinion about the role of prevention of cardiovascular disease, the role of cardiovascular diseas risk extimation in the prevention of cardiovascular disease, and the status in cardiovascular prevention?
    《国际循环》:您能就心血管疾病预防的作用、在心血管疾病预防中心血管疾病风险评估的作用以及心血管疾病预防现状谈谈您的看法吗?

    Dr Philip Greenland: Well,I think the first question of the role of prevention of cardiovascular disease is kind of a major emphasis of cardiology today, and we know so much about the risk factors and the treatment oppertunity. In terms of status unfortunately we are still finding evidence that in many countries the identification of risk factors is still sub-standard and the treatment intensity of risk factors is still sub-standard.   This session spends a lot of time obviously talking about methods of identify risk. One of the things I find at this point in our research as mentioned in my summay is that even though we are able to improve risk estimation and we have some methods which can substantially improve and properly certify people, the problem is that we still end up with a fairly large proportion of the events in people who are predicted to be low risk. If we are really committed to a strategy of high risk prevention which is the drug based approach that means inevitably that all those people who are predicted to be low risk are not going to get much treatment. At the same time when we are doing this risk assessment in clinical practice, we have to be very aware that what we really want to do is also move the entire risk in the population down. That would probably most appropriately be done by broad population based risk and lifestyle interventions even the risk is lower.

    Philip Greenland教授:我认为,第一个问题有关心血管疾病预防的作用是当今心脏病学的一个主要重点。我们对危险因素和治疗时机了解颇多。而谈及预防性努力的情况,不幸的是,我们还在寻找证据,在很多国家中危险因素的定义仍然不合标准,且对危险因素治疗的强度也不合标准。本次会议显然花费了大量时间来讨论识别风险的方法。如同我在本次AHA会议结束时的总结中所提到的那样,在这一点上我在我们研究中的一个发现是,即使我们能够改进风险评估,我们有一些能实质性改善且正确识别人群的方法,问题是在那些被预测为低风险的人群中最终仍然有相当大比例的事件发生。如果我们真的致力于基于药物方法的高风险预防策略,就意味着所有那些被预测为低风险的人群将必然不会得到很多治疗。同时,当我们在临床实践中进行这种风险评估时,我们必须非常清楚,我们真正想要做的还是降低人群的整体风险。这很可能是最恰当的要做的事情,通过基于广泛人群的危险因素和生活方式干预来确保人群整体风险较低。

[1]  [2]  [3]  [4]  下一页

版面编辑:李雅峰


Philip.Greenland预防

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530